Drugs that contain Torsemide
1. Soaanz patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10154963 | SARFE PHARMS | Controlled-release formulations comprising Torsemide |
Oct, 2033
(9 years from now) | |
Market Authorisation Date: 14 June, 2021
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
SOAANZ family patents
